Budget Amount *help |
¥3,510,000 (Direct Cost: ¥2,700,000、Indirect Cost: ¥810,000)
Fiscal Year 2016: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2015: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2014: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
|
Outline of Final Research Achievements |
This research project aimed to understand how renal erythropoietin-producing cells (REPCs) lose their physiological function and gain pathological characteristics under kidney injury. We used multiple mouse models and elucidated that the hypoxia signaling cascade is attenuated in inflammatory milieu in injured kidneys. We further found that activating hypoxia signaling by means of inhibiting HIF proryl hydroxylase, a master negative regulatory system of hypoxia responses, restored REPCs physiological function in hypoxic injured kidneys. Our research provides an explanation how PHD inhibitors, which are clinical trial for renal anemia, might work in injured kidneys in CKD patients.
|